Nuvectis Pharma (NVCT)
(Delayed Data from NSDQ)
$6.58 USD
+0.18 (2.81%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $6.57 -0.01 (-0.15%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth A Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/14/2024
Time: -- |
6/2024 | $-0.26 | 0.00% |
Earnings Summary
For their last quarter, Nuvectis Pharma (NVCT) reported earnings of -$0.25 per share, beating the Zacks Consensus Estimate of $-0.40 per share. This reflects a positive earnings surprise of 37.50%. Look out for NVCT's next earnings release expected on August 14, 2024. For the next earning release, we expect the company to report earnings of -$0.26 per share, reflecting a year-over-year increase of 31.58%.
Earnings History
Price & Consensus
Zacks News for NVCT
Down -36.49% in 4 Weeks, Here's Why You Should You Buy the Dip in Nuvectis Pharma, Inc. (NVCT)
NVCT: What are Zacks experts saying now?
Zacks Private Portfolio Services